Increased Incidence of Neuroleptic-Induced Perioral Movements in the Rat by Hyperglycemia

References

• Baldessarini R. J., Tarsy D. Mechanisms underlying tardive dyskinesia. The basal ganglia, M. D. Yahr. Raven Press, New York 1976
   Google Scholar
• Barbeau A. Experience clinique avec le tolbutamide dans la maladie de Parkinson. Union Medicine Canadienxe 1961; 90: 147–151
   PubMedGoogle Scholar
• Baskin D. G., Wilcox B. J., Figlewicz D. P., Dona D. M. Insulin and insulin-like growth factors in the CNS. Trends in Neuroscience 1988; 11: 107–110
   PubMed Web of Science ®Google Scholar
• Brambilla F., Guastalla A., Guerrini A., Riggi F., Rovere C., Zanoboni A., Zanoboni-Muciaccina W. Glucose-insulin metabolism in chronic schizophrenia. Diseases of the nervous system 1976; 37: 98–103
   PubMedGoogle Scholar
• Burt D. R., Creese I., Snyder S. H. Anti-schizophrenic drugs: chronic treatment elevates dopamine receptor binding in the brain. Science 1977; 196: 326–328
   PubMed Web of Science ®Google Scholar
• Crandall R. A., Gillis M. A., Fernstrom J. D. Reduction in brain serotonin synthesis rate in streptozocin-diabetic rats. Endocrinology 1981; 109: 310–316
   PubMed Web of Science ®Google Scholar
• Creese I., Burt D. R., Snyder S. H. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science 1977; 197: 596–599
   PubMed Web of Science ®Google Scholar
• Dorris R. L. Influence of glucose on amine release from rat corpus striaturn. Neuropharmacology 1978; 17: 157–162
   PubMedGoogle Scholar
• Gallager D. W., Pert A., Bunney W. E. Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium. Nature 1978; 273: 309–311
   PubMed Web of Science ®Google Scholar
• Garcia-Sevilla J. A., Antee L., Magnusson T., Carlsson A. Opiate receptors mediate changes in monoamine synthesis in rat brain. Journal of Pharmacy and Pharmacology 1978; 30: 613–618
   PubMedGoogle Scholar
• Jeste D. V., Wyatt R. J. Dogma disputed: Is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity. Journal of Clinical Psychiatry 1981; 42: 455–457
   PubMed Web of Science ®Google Scholar
• Kane J., Woerner M., Lieberman J. Tardive dyskinesia: prevalence, incidence, and risk factors. Journal of Clinical Psychopharmacology 1988; 8: 52S–56S, (suppl)
   PubMed Web of Science ®Google Scholar
• Kolla M. G., Williams B. B. Effect of hyperglycemia on biogenic amines, beta-endorphin and insulin of the rat brain. Hormones and Metabolic Research 1984; 16: 16–19
   PubMedGoogle Scholar
• Kozell L., Sandyk R., Wagner G. C., Fisher H. The effects of L-tryptophan on haloperidol-induced movement disorder in the rat. Life Sciences 1987; 41: 1739–1744
   PubMed Web of Science ®Google Scholar
• Le Douarin C., Oblin A., Fage D., Scatton B. Influence of lithium on biochemical manifestations of striatal dopamine terget cell supersensitivity induced by prolonged haloperidol treatment. European Journal of Pharmacology 1983; 93: 55–62
   PubMedGoogle Scholar
• Lillker S. L. Prevalence or diabetes in a manic-depressive population. Comprehensive Psychiatry 1900; 21: 270–274
   Google Scholar
• Lozovsky D., Saller C. F., Kopin I. J. Dopamine receptor binding is increased in diabetic rats. Science 1981; 214: 1031–1032
   PubMed Web of Science ®Google Scholar
• Lozovsky D., Saller C. F., Kopin I. J. Lithium and prevention of dopamine receptor supersensitivity in diabetic rats. American Journal of Psychiatry 1983; 140: 613–614
   PubMedGoogle Scholar
• Mackenzie R. G., Trulson M. E. Effects of insulin and streptozocin-induced diabetes on brain tryptophan and serotonin metabolism in rats. Journal of Neurochemistry 1978; 30: 205–211
   PubMedGoogle Scholar
• Manzanares J., Canton R., Grande C., Benedi J., Zaragosa F. Amphetamine and chlopro-mazine modify cerebral insulin levels in rats. Life Sciences 1986; 42: 21–24
   Google Scholar
• Mukherjee S., Bilder R. M., Sackeim H. A. Tardive dyskinesia and glucose metabolism. Archives of General Psychiatry 1986; 43: 193–194
   Web of Science ®Google Scholar
• Mukherjee S., Wisniewski A., Bilder R. M., Sackeim H. A. Possible association between tardive dyskinesia and altered carbohydrate metabolism. Archives of General Psychiatry 1985; 42: 205–206
   PubMedGoogle Scholar
• Pang S. F., Tang P. L. Alloxan-induced diabetes and the pineal gland: Differential effects on the levels of pineal N-acetylserotonin, pineal melatonin, end serum melatonin. Journal of Pineal Research 1985; 2: 79–85
   PubMed Web of Science ®Google Scholar
• Pert A., Rosenblatt J. E., Sivit C., Pert C. B., Bunney W. E. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 1978; 201: 171–172
   PubMed Web of Science ®Google Scholar
• Psychoyos S., Stanton B. R., Atkins C. D. The influence of glucose. other monosaccharides and ascorbic acid on tyrosine hydroxylase activity of rat striatal synaptosomes. Life Sciences 1979; 25: 1119–1122
   PubMedGoogle Scholar
• Reches A., Wagner H. R., Jackson V., Fahn S. Chronic lithium administration has no effect on haloperidol-induced supersensitivity of pre-and postsynaptic dopamine receptors in rat brain. Brain Research 1982; 246: 172–176
   PubMedGoogle Scholar
• Rupniak N. M. J., Jenner P., Marsden C. D. Pharmacological characterization of spontaneous or drug-associated purposeless chewing movements in rats. Psychopharmacology 1985; 85: 71–79
   PubMed Web of Science ®Google Scholar
• Saller C. F., Kopin I. J. Glucose potentiates haloperidol-induced catalepsy. Life Sciences 1981; 29: 2337–2341
   PubMedGoogle Scholar
• Saller C. F., Chiodo L. A. Glucose suppresses basal firing and haloperidol-induced increases in firing rate of central dopaminergic neurons. Science 1980; 210: 1269–1271
   PubMedGoogle Scholar
• Sandyk R. Dopamine and insulin interact to modulate in vitro glucose transport in rat adipocytes. International Journal of Neuroscience 1984; 43: 9–14
   Google Scholar
• Sandyk R., Bamford C. R. Neuroleptic-mediated hypothalamic deregulation of central insulin and peripheral glucose metabolism in tardive dyskinesia: A hypothesis. International Journal of Neuroscience 1988; 40: 213–216
   PubMed Web of Science ®Google Scholar
• Sandyk R., Bamford C. R., Fisher H. Efficacy of L-tryptophan in neuroleptic-induced tardive dyskinesia. Neurology 1988; 38: 128, (suppl.)
   Google Scholar
• Sandyk R., Consroe P., Lacono R. P. L-tryptophan in drug-induced movement disorder with insomnia. New England Journal of Medicine 1986; 314: 1257
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Increased and severity of neuroleptic-induced movement disorder in pinealectomized rats. International Journal of Neuroscience., (in press)
   Google Scholar
• Sandyk R., Gillman M. A. Tardive dyskinesia and glucose metabolism. Archives of General Psychiatry 1986; 43: 192–193
   PubMedGoogle Scholar
• Sandyk R. Tardive dyskinesia in bipolar patients: A possible role of pineal melatonin. Internarional Journal of Neuroscience.
   Google Scholar
• Simon W., Garvey J. T. Glucose intolerance in chronic schizophrenia and senile states. A.M.A. Archives of Neurology and Psychiatry 1951; 65: 717–722
   PubMedGoogle Scholar
• Staunton D. A., Magistrelli P. J., Shoemaker W. J., Bloom F. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity. Brain Research 1982; 232: 391–396
   PubMedGoogle Scholar
• Tang F., Man S. Y., LO Y. M. Met-enkephalin and beta-endorphin contents in the hypothalamus and pituitary of alloxan-diabetic rats. Neuroscience Letters 1987; 28: 54, (suppl.)
   Google Scholar
• Trulson M. E., Himmel C. D. Decreased brain dopamine synthesis rate and increased (3H) spiperone binding in streptozocin-diabetic rats. Journal of Neurochemistry 1983; 40: 1456–1459
   PubMedGoogle Scholar
• Van Woert M. H., Mueller P. S. Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa. Clinical Pharmacology and Therapeutics 1971; 12: 360–365
   PubMedGoogle Scholar